| 1 |
HBO: a possible supplementary therapy for oral potentially malignant disorders |
|
|
| Xiaojing Ye,Jing Zhang,Rui Lu,Gang Zhou |
|
| Medical Hypotheses. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Expression of tumor necrosis factor a and its correlation with severity of oral submucous fibrosis: a case-control study |
|
|
| Sonia Sodhi,Jasmeet Singh Sodhi,Neha Khambete,Rahul Kumar,Manjula Marthala,Neha Kaur Sodhi |
|
| Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2014; 117(6): 704 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Inflammation in the context of oral cancer |
|
|
| L. Feller,M. Altini,J. Lemmer |
|
| Oral Oncology. 2013; 49(9): 887 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Pathogenesis and therapeutic intervention of oral submucous fibrosis |
|
|
| Yoithapprabhunath, T.R. and Maheswaran, T. and Dineshshankar, J. and Anusushanth, A. and Sindhuja, P. and Sitra, G. |
|
| Journal of Pharmacy and Bioallied Sciences. 2013; 5(SUPPL.1): S85-S88 |
|
| [Pubmed] [Google Scholar] |
|
| 5 |
Arecoline suppresses HaCaT cell proliferation through cell cycle regulatory molecules |
|
|
| Zhou, Z.-S. and Li, M. and Gao, F. and Peng, J.-Y. and Xiao, H.-B. and Dai, L.-X. and Lin, S.-R. and Zhang, R. and Jin, L.-Y. |
|
| Oncology Reports. 2013; 29(6): 2438-2444 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
Dietary copper: A novel predisposing factor for oral submucous fibrosis? |
|
|
| Arakeri, G. and Brennan, P.A. |
|
| Medical Hypotheses. 2013; 80(3): 241-243 |
|
| [Pubmed] [Google Scholar] |
|
